Targeting pathological brain activity-related to neuroinflammation through scRNA-seq for new personalized therapies in Parkinson’s disease

Saved in:
Bibliographic Details
Main Authors: Daniela Mirzac, Manuel Bange, Sebastian Kunz, Phil L. de Jager, Sergiu Groppa, Gabriel Gonzalez-Escamilla
Format: Article
Language:English
Published: Nature Publishing Group 2025-01-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-024-02086-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544225042202624
author Daniela Mirzac
Manuel Bange
Sebastian Kunz
Phil L. de Jager
Sergiu Groppa
Gabriel Gonzalez-Escamilla
author_facet Daniela Mirzac
Manuel Bange
Sebastian Kunz
Phil L. de Jager
Sergiu Groppa
Gabriel Gonzalez-Escamilla
author_sort Daniela Mirzac
collection DOAJ
format Article
id doaj-art-033a10ea91ce4bcea576623b5c634660
institution Kabale University
issn 2059-3635
language English
publishDate 2025-01-01
publisher Nature Publishing Group
record_format Article
series Signal Transduction and Targeted Therapy
spelling doaj-art-033a10ea91ce4bcea576623b5c6346602025-01-12T12:41:38ZengNature Publishing GroupSignal Transduction and Targeted Therapy2059-36352025-01-011011310.1038/s41392-024-02086-7Targeting pathological brain activity-related to neuroinflammation through scRNA-seq for new personalized therapies in Parkinson’s diseaseDaniela Mirzac0Manuel Bange1Sebastian Kunz2Phil L. de Jager3Sergiu Groppa4Gabriel Gonzalez-Escamilla5Department of Neurology, Universitätsmedizin Mainz and Saarland University Hospital HomburgDepartment of Neurology, Universitätsmedizin Mainz and Saarland University Hospital HomburgInstitute of Immunology, Universitätsmedizin MainzCenter for Translational & Computational Neuroimmunology, Department of Neurology and the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University Irving Medical CenterDepartment of Neurology, Universitätsmedizin Mainz and Saarland University Hospital HomburgDepartment of Neurology, Universitätsmedizin Mainz and Saarland University Hospital Homburghttps://doi.org/10.1038/s41392-024-02086-7
spellingShingle Daniela Mirzac
Manuel Bange
Sebastian Kunz
Phil L. de Jager
Sergiu Groppa
Gabriel Gonzalez-Escamilla
Targeting pathological brain activity-related to neuroinflammation through scRNA-seq for new personalized therapies in Parkinson’s disease
Signal Transduction and Targeted Therapy
title Targeting pathological brain activity-related to neuroinflammation through scRNA-seq for new personalized therapies in Parkinson’s disease
title_full Targeting pathological brain activity-related to neuroinflammation through scRNA-seq for new personalized therapies in Parkinson’s disease
title_fullStr Targeting pathological brain activity-related to neuroinflammation through scRNA-seq for new personalized therapies in Parkinson’s disease
title_full_unstemmed Targeting pathological brain activity-related to neuroinflammation through scRNA-seq for new personalized therapies in Parkinson’s disease
title_short Targeting pathological brain activity-related to neuroinflammation through scRNA-seq for new personalized therapies in Parkinson’s disease
title_sort targeting pathological brain activity related to neuroinflammation through scrna seq for new personalized therapies in parkinson s disease
url https://doi.org/10.1038/s41392-024-02086-7
work_keys_str_mv AT danielamirzac targetingpathologicalbrainactivityrelatedtoneuroinflammationthroughscrnaseqfornewpersonalizedtherapiesinparkinsonsdisease
AT manuelbange targetingpathologicalbrainactivityrelatedtoneuroinflammationthroughscrnaseqfornewpersonalizedtherapiesinparkinsonsdisease
AT sebastiankunz targetingpathologicalbrainactivityrelatedtoneuroinflammationthroughscrnaseqfornewpersonalizedtherapiesinparkinsonsdisease
AT philldejager targetingpathologicalbrainactivityrelatedtoneuroinflammationthroughscrnaseqfornewpersonalizedtherapiesinparkinsonsdisease
AT sergiugroppa targetingpathologicalbrainactivityrelatedtoneuroinflammationthroughscrnaseqfornewpersonalizedtherapiesinparkinsonsdisease
AT gabrielgonzalezescamilla targetingpathologicalbrainactivityrelatedtoneuroinflammationthroughscrnaseqfornewpersonalizedtherapiesinparkinsonsdisease